A Study of Apabetalone in Subjects With Long -COVID

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Post-Acute COVID-19 Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Speciality Hospital, Amman, Jordan
Contact: Study coordinator (Mohammed Hasan Jafar, MD) · r.elayyan70@gmail.com · (+962)795112543
MNGHA- King Abdulaziz Hospital, Al Mubarraz, Saudi Arabia
Contact: Study coordinator (Maram Al Subaiee, MD) · CTS_feasibility@MNGHA.MED.SA · (+966)-542725431
Al Kuwait Hospital, Dubai, Dubai, United Arab Emirates
Contact: Study coordinator (Suad Hannawi, MD) · suadhannawi@gmail.com · +971 50 551 6624

Study leads

Michael Sweeney, MD
Study Director
Resverlogix Corp

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

SARS-CoV Infection · COVID-19

Abroad (travel likely)RecruitingPHASE2

Dallas, United States

Care for Veterans Post-COVID-19

Post-Acute COVID-19 Syndrome

Abroad (travel likely)Recruiting

East Orange, United States

Prevalence of Long COVID-19 in the Canary Islands

COVID-19

Abroad (travel likely)Recruiting

Las Palmas de Gran Canaria, Spain

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Long COVID · Long Covid19 · Post-Acute COVID-19

Abroad (travel likely)Recruiting

New York, United States